Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
Grenfell RFQ, Almeida NBF, Filgueiras PS, Corsini CA, Gomes SVC, de Miranda DAP, Lourenço AJ, Martins-Filho OA, de Oliveira JG, Teixeira-Carvalho A, Campos GRF, Nogueira ML, Alves PA, Fernandes GR, Castilho LR, Lima TM, de Abreu DPB, Alvim RGF, Silva TBS, Jeremias WJ, Otta DA, Campi-Azevedo AC; Immunita-001 Team. Grenfell RFQ, et al. Among authors: lourenco aj. Front Immunol. 2022 Jun 9;13:918896. doi: 10.3389/fimmu.2022.918896. eCollection 2022. Front Immunol. 2022. PMID: 35757764 Free PMC article. Clinical Trial.
Rapid antigen test as a tool for the identification of SARS-CoV-2 infection and its potential as a self-testing device.
Filgueiras PS, Corsini CA, Almeida NBF, Pedrosa MLC, Miranda DAP, Gomes SVC, Assis JV, Silva RA, Medeiros MIVARC, Lourenço AJ, Bicalho CMF, Vilela RVR, Jeremias WJ, Fernandes GDR, Queiroz RFGE. Filgueiras PS, et al. Among authors: lourenco aj. Rev Soc Bras Med Trop. 2023 May 22;56:e01672022. doi: 10.1590/0037-8682-0167-2022. eCollection 2023. Rev Soc Bras Med Trop. 2023. PMID: 37222349 Free PMC article.
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection.
Corsini CA, Filgueiras PS, Almeida NB, Miranda DA, Gomes SV, Lourenço AJ, Bicalho CM, Assis JV, Amorim RN, Silva RA, Vilela RV, Lima TM, Abreu DP, Alvim RG, Castilho LR, Martins-Filho OA, Otta DA, Grenfell RF. Corsini CA, et al. Among authors: lourenco aj. Sci Rep. 2023 Oct 30;13(1):18606. doi: 10.1038/s41598-023-43263-y. Sci Rep. 2023. PMID: 37903875 Free PMC article.
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Corsini CA, Martins PFDS, Filgueiras PS, Lourenço AJ, Lima AES, Gomes SVC, Jeremias WJ, Alves PA, Fernandes GDR, Castro LLME, de Carvalho AT, Azevedo ACC, Curimbaba CAL, Lorencini DA, Junior EM, da Silva VM, Cervi MC, Borges MC, Nogueira ML, Campos GRF, Correa PRL, Carvalho TML, Dos Reis JGAC, Reis EVS, Castilho LDR, de Lima PR, do Nascimento JPR, de Oliveira JG, Filho OAM, Grenfell RFQE; Immunita team. Corsini CA, et al. Among authors: lourenco aj. Res Sq [Preprint]. 2024 Feb 29:rs.3.rs-3931021. doi: 10.21203/rs.3.rs-3931021/v1. Res Sq. 2024. PMID: 38464059 Free PMC article. Preprint.